Cureios Health Eapp Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.28 M
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -33.57%
- Profit Growth -300.83%
- Ebitda -300.83%
- Net Worth -511.66%
- Total Assets 57746.51%
About Cureios Health Eapp
Cureios Health Eapp Private Limited (CHEPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 11 April 2017 (Seven years and ten months 14 days old ). Its registered office is in Coimbatore, Tamil Nadu, India.
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.28 M, as per Ministry of Corporate Affairs (MCA) records.
Sadasivam Vijay, Velayuthaswamy Nandagopal, and Karuppiah Mathan serve as directors at the Company.
Company Details
- Location
Coimbatore, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U72900TZ2017PTC028786
- Company No.
028786
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Apr 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Who are the key members and board of directors at Cureios Health Eapp?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sadasivam Vijay  | Director | 11-Apr-2017 | Current |
| Velayuthaswamy Nandagopal | Director | 11-Apr-2017 | Current |
| Karuppiah Mathan | Director | 11-Apr-2017 | Current |
Financial Performance of Cureios Health Eapp.
Cureios Health Eapp Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 33.57% decrease. The company also saw a substantial fall in profitability, with a 300.83% decrease in profit. The company's net worth observed a substantial decline by a decrease of 511.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cureios Health Eapp?
In 2019, Cureios Health Eapp had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Clinix Health Services Private LimitedKaruppiah Mathan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cureios Health Eapp?
Unlock and access historical data on people associated with Cureios Health Eapp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cureios Health Eapp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cureios Health Eapp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.